ATE137956T1 - Zäpfchen mit verdauerter verabreichung und verfahren zur herstellung - Google Patents
Zäpfchen mit verdauerter verabreichung und verfahren zur herstellungInfo
- Publication number
- ATE137956T1 ATE137956T1 AT92203989T AT92203989T ATE137956T1 AT E137956 T1 ATE137956 T1 AT E137956T1 AT 92203989 T AT92203989 T AT 92203989T AT 92203989 T AT92203989 T AT 92203989T AT E137956 T1 ATE137956 T1 AT E137956T1
- Authority
- AT
- Austria
- Prior art keywords
- suppository
- weight
- ingredient
- digested
- administration
- Prior art date
Links
- 239000000829 suppository Substances 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 239000004615 ingredient Substances 0.000 abstract 2
- 239000002511 suppository base Substances 0.000 abstract 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000001913 cellulose Substances 0.000 abstract 1
- 229920002678 cellulose Polymers 0.000 abstract 1
- 230000002209 hydrophobic effect Effects 0.000 abstract 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 abstract 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 abstract 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 abstract 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 abstract 1
- 238000002844 melting Methods 0.000 abstract 1
- 230000008018 melting Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Vessels, Lead-In Wires, Accessory Apparatuses For Cathode-Ray Tubes (AREA)
- Feed For Specific Animals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL9102142A NL9102142A (nl) | 1991-12-20 | 1991-12-20 | Zetpillen met vertraagde afgifte en werkwijze voor de bereiding daarvan. |
| CA002099557A CA2099557A1 (en) | 1991-12-20 | 1993-07-02 | Sustained release suppositories and a process for preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE137956T1 true ATE137956T1 (de) | 1996-06-15 |
Family
ID=25676329
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92203989T ATE137956T1 (de) | 1991-12-20 | 1992-12-17 | Zäpfchen mit verdauerter verabreichung und verfahren zur herstellung |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5436009A (de) |
| EP (1) | EP0550100B1 (de) |
| JP (1) | JPH05245187A (de) |
| AT (1) | ATE137956T1 (de) |
| CA (1) | CA2099557A1 (de) |
| DE (1) | DE69210787T2 (de) |
| DK (1) | DK0550100T3 (de) |
| ES (1) | ES2090490T3 (de) |
| GR (1) | GR3020828T3 (de) |
| NL (1) | NL9102142A (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2288117A (en) * | 1994-03-01 | 1995-10-11 | Euro Celtique Sa | Sustained release morphine |
| US5962477A (en) * | 1994-04-12 | 1999-10-05 | Adolor Corporation | Screening methods for cytokine inhibitors |
| US6190691B1 (en) | 1994-04-12 | 2001-02-20 | Adolor Corporation | Methods for treating inflammatory conditions |
| US5587224A (en) * | 1995-03-27 | 1996-12-24 | Xerox Corporation | Developing apparatus including a coated developer roller |
| US6573282B1 (en) | 1995-09-12 | 2003-06-03 | Adolor Corporation | Peripherally active anti-hyperalgesic opiates |
| US5849761A (en) * | 1995-09-12 | 1998-12-15 | Regents Of The University Of California | Peripherally active anti-hyperalgesic opiates |
| WO1998000143A1 (en) * | 1996-06-28 | 1998-01-08 | Knoll Pharmaceutical Company | Slow release pharmaceutical compositions and methods of making same |
| PT946155E (pt) * | 1996-12-23 | 2006-07-31 | Sla Pharma Ag | Composicao farmaceutica para tratar incontinencia fecal e prurido anal |
| US20040047910A1 (en) * | 2000-07-07 | 2004-03-11 | Christian Beckett | Suppository and composition comprising at least one polyethylene glycol |
| GB0130763D0 (en) * | 2001-12-21 | 2002-02-06 | Norgine Res Ltd | Treatment methods |
| US10966924B2 (en) * | 2018-09-04 | 2021-04-06 | Babak Ghalili | Veterinary cannabinoid, menthol and anesthetic compositions and methods |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2538127A (en) * | 1948-02-26 | 1951-01-16 | Searle & Co | Medicated suppositories and bases therefor |
| US3870790A (en) * | 1970-01-22 | 1975-03-11 | Forest Laboratories | Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose |
| DE2530563C2 (de) * | 1975-07-09 | 1986-07-24 | Bayer Ag, 5090 Leverkusen | Analgetische Arzneimittel mit vermindertem Mißbrauchspotential |
| GB1593261A (en) * | 1976-07-23 | 1981-07-15 | Inveresk Res Int | Controlled release suppository |
| US4406883A (en) * | 1976-07-23 | 1983-09-27 | Merrell Dow Pharmaceuticals Inc. | Controlled release suppositories consisting essentially of a linear polymer particularly, polyvinyl pyrrolidones |
| JPS6042766B2 (ja) * | 1978-12-09 | 1985-09-25 | 日本化薬株式会社 | 基剤 |
| JPS57140710A (en) * | 1981-02-24 | 1982-08-31 | Shionogi & Co Ltd | Capsule agent for rectal administration |
| US4369172A (en) * | 1981-12-18 | 1983-01-18 | Forest Laboratories Inc. | Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose |
| CA1207231A (en) * | 1982-08-24 | 1986-07-08 | Hans W. Zulliger | Medicated suppository |
| US4999342A (en) * | 1988-08-16 | 1991-03-12 | Ortho Pharmaceutical Corporation | Long lasting contraceptive suppository composition and methods of use |
| CH678697A5 (de) * | 1989-04-03 | 1991-10-31 | Warner Lambert Co | |
| JPH03170419A (ja) * | 1989-11-30 | 1991-07-24 | Torii Yakuhin Kk | 塩酸モルヒネの直腸投与製剤 |
-
1991
- 1991-12-20 NL NL9102142A patent/NL9102142A/nl active Search and Examination
-
1992
- 1992-12-15 US US07/990,888 patent/US5436009A/en not_active Expired - Fee Related
- 1992-12-17 DE DE69210787T patent/DE69210787T2/de not_active Expired - Fee Related
- 1992-12-17 DK DK92203989.6T patent/DK0550100T3/da active
- 1992-12-17 EP EP92203989A patent/EP0550100B1/de not_active Expired - Lifetime
- 1992-12-17 AT AT92203989T patent/ATE137956T1/de not_active IP Right Cessation
- 1992-12-17 ES ES92203989T patent/ES2090490T3/es not_active Expired - Lifetime
- 1992-12-21 JP JP4340181A patent/JPH05245187A/ja active Pending
-
1993
- 1993-07-02 CA CA002099557A patent/CA2099557A1/en not_active Abandoned
-
1996
- 1996-08-16 GR GR960402192T patent/GR3020828T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2090490T3 (es) | 1996-10-16 |
| NL9102142A (nl) | 1993-07-16 |
| DK0550100T3 (da) | 1996-10-14 |
| EP0550100A1 (de) | 1993-07-07 |
| GR3020828T3 (en) | 1996-11-30 |
| US5436009A (en) | 1995-07-25 |
| JPH05245187A (ja) | 1993-09-24 |
| DE69210787D1 (de) | 1996-06-20 |
| EP0550100B1 (de) | 1996-05-15 |
| DE69210787T2 (de) | 1997-01-02 |
| CA2099557A1 (en) | 1995-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO176549C (no) | Fremgangsmåte for fremstilling av L-dopa-kjerner med 2 overtrekk | |
| ATE137956T1 (de) | Zäpfchen mit verdauerter verabreichung und verfahren zur herstellung | |
| ES2193658T3 (es) | Procedimiento para la preparacion de formulaciones acuosas para uso oftalmico. | |
| NO162103C (no) | Fremgangsmaate for fremstilling av et farmasoeytisk preparat | |
| NO913136L (no) | Fremgangsmaate for fremstilling av et preparat for oeyedraaper | |
| NO307594B1 (no) | Fremgangsmåte for fremstilling av en tørr, hydratisert cefalosporinpulverformulering, og farmsøytisk preparat | |
| NO914157D0 (no) | Fremgangsmaate for fremstilling av et farmasoeytisk preparat | |
| GR900100481A (el) | Μέ?οδος παρακευής υδατικού αιωρήματος για ουσιαστικά αδιάλυτους στο νερό ενεργούς παράγοντες. | |
| ATE165360T1 (de) | Triazolylthiomethylthiocephalosporin- hydrochlorid, sein kristallines hydrat und seine herstellung | |
| ATE149826T1 (de) | Verfahren zur herstellung von festen pharmazeutischen retardformen | |
| HU901085D0 (en) | Process for producing substituted benzimidazole and pharmaceutical preparatives containing it | |
| DE3574933D1 (de) | Feste arzneizubereitung enthaltend nitrendipin und verfahren zur ihrer herstellung. | |
| KR960034205A (ko) | 피페리딘 유도체와 그것의 제조방법 및 치료적 이용 | |
| MX9205461A (es) | Solucion acuosa estable de esparfloxacina y metodopara su preparacion | |
| NO924549L (no) | Fremgangsmaate for fremstilling av vandig suspensjon | |
| ATE288269T1 (de) | Arzneizusammensetzungen und herstellungsverfahren von ergotalkaloidhaltigen arzneizusammensetzungen mit verzögerter wirkstoffabgabe und verbesserter bioverfügbarkeit | |
| ATE160938T1 (de) | Feste orale pharmazeutische zubereitung mit gemfibrozil als aktiver inhaltsstoff und verfahren zur herstellung | |
| HUT46921A (en) | Process for producing 3-phenyl-7h-thiazolo /3,2-b//1,2,4/ triazin-7-ones, certain intermediaries thereof and pharmaceutics comprising such active ingredient | |
| DE59002790D1 (de) | Verfahren zur Herstellung einer Galenischen Zubereitung mit optimaler Bioverfügbarkeit des Wirkstoffs 2-Hydroxy-5-methyllaurophenonoxime (HMLO). | |
| FR2787448B3 (fr) | Ester d'alkyle inferieur de l'acide 3-(3,4-dihalogenophenyl) -2,6-dioxopiperidine3-propionique et son mode de preparation | |
| HU904109D0 (en) | Process for the production of solid medical preparations | |
| ATE105184T1 (de) | D8- und d9-prostaglandin-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung. | |
| FR2608606B1 (fr) | Derives d'acide dibenzo(be)oxepinne-acetique, leur preparation et leur application en therapeutique | |
| NO961657L (no) | Dibenz[b,eÅoksepinderivater, fremgangsmåte for fremstilling samt legemiddel inneholdende slike | |
| FI953927A7 (fi) | Menetelmä lääkeaineina käyttökelpoisten milbemysiinin johdannaisten valmistamiseksi |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |